Show simple item record

dc.contributor.authorBista, D.
dc.contributor.authorChalmers, Leanne
dc.contributor.authorPeterson, G.
dc.contributor.authorBereznicki, L.
dc.date.accessioned2017-11-24T05:26:41Z
dc.date.available2017-11-24T05:26:41Z
dc.date.created2017-11-24T04:48:44Z
dc.date.issued2017
dc.identifier.citationBista, D. and Chalmers, L. and Peterson, G. and Bereznicki, L. 2017. Patient Characteristics and Antithrombotic Prescribing Patterns in Patients with Atrial Fibrillation in Tasmania. Clinical and Applied Thrombosis/Hemostasis. 23 (5): pp. 438-444.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/58636
dc.identifier.doi10.1177/1076029615623375
dc.description.abstract

© 2017 SAGE Publications. Limited data are available on atrial fibrillation (AF) and its clinical management and outcomes from an Australian perspective. This study was designed to examine the patient characteristics and antithrombotic treatment patterns among patients with AF in Tasmania, Australia. This retrospective observational study reviewed and followed patients with AF admitted to Tasmania's 3 major hospitals between January 2011 and June 2012. Patients were excluded if they had only 1 episode of AF that reverted spontaneously or upon cardioversion without any documented recurrences. We reviewed the records of 2502 patients (=18 years), and1469 were subsequently included in the study. The mean (±standard deviation [SD]) age of the patients was 76 (±12.3) years. The mean (± SD) CHADS 2 score was 2.1 (±1.3), and 65.7% had a score =2. In total, only 55.6% of patients with CHADS 2 score =2 were receiving anticoagulation and 9.9% were not receiving any antithrombotic treatment, whereas 85.4% of those at low risk (score 0) were on antithrombotic therapy. Hospitalization was associated with a significant increase in the rate of combination (antiplatelet plus anticoagulant) therapy (P < .001). Suboptimal use of antithrombotic therapy highlights the need to improve AF management in our jurisdiction.

dc.titlePatient Characteristics and Antithrombotic Prescribing Patterns in Patients with Atrial Fibrillation in Tasmania
dc.typeJournal Article
dcterms.source.volume23
dcterms.source.number5
dcterms.source.startPage438
dcterms.source.endPage444
dcterms.source.issn1076-0296
dcterms.source.titleClinical and Applied Thrombosis/Hemostasis
curtin.departmentSchool of Pharmacy
curtin.accessStatusFulltext not available


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record